Can a toxin gene NAAT be used to predict toxin EIA and the severity of Clostridium difficile infection?

Abstract excerpt

Diagnosis of C. difficile infection (CDI) is controversial because of the many laboratory methods available and their lack of ability to distinguish between carriage, mild or severe disease. Here we describe whether a low C. difficile toxin B nucleic acid amplification test (NAAT) cycle threshold (CT) can predict toxin EIA, CDI severity and mortality. A three-stage algorithm was employed for CDI testing,...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Clostridium difficile and Clostridium perfringens research
• Share to Helicobacter pylori-related gastroenterology studies
• Share to Nosocomial Infections in ICU